Tuesday, 25 May 2021

Global Helicobacter Pylori Diagnostics Market Research Report

 The findings reviewed by GME stated that the Global Helicobacter Pylori Diagnostics Market would grow at a CAGR value of 7.4 percent from 2021 to 2026. With drastically increasing advancements and less complex diagnostic processes, the reliability and demand for helicobacter pylori diagnostics are increasing. Also, most developing countries have unsanitary water services and facilities, along with a lack of awareness about personal care; the helicobacter pylori bacterial infection is increasing, thus accelerating the growth within the market.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on Helicobacter Pylori Diagnostics Market - Forecast to 2026” 

https://www.globalmarketestimates.com/market-report/global-helicobacter-pylori-diagnostics-market-3180

By Technology (Immunoassays, POC, and Molecular Diagnostics), By End-User (Hospitals, Diagnostics Laboratories, and Clinics), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

 

Key Market Insights

·         Growing contagious disease frequency, enhanced cost-effectiveness of helicobacter pylori infection detection, and increased public knowledge about pathogens are the main driving forces.

·         Immunoassay is preferred and utilized the most for diagnosing the presence of helicobacter pylori bacteria, thus holding the most significant share within the market.

·         The hospitals are analyzed to hold the largest share within the Helicobacter Pylori diagnostics market.

·         North America is presumed to dominate because of advanced & developed medical & healthcare sectors.

·         Alpha Laboratories, Biohit, Bio-Rad Laboratories, CorisBioConcept, Thermo Fisher Scientific, Epitope Diagnostics, Quest Diagnostics, Meridian Bioscience, F. Hoffmann-La Roche, and CertestBiotec are few prominent competitors in the market.

 

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-helicobacter-pylori-diagnostics-market-3180

Technology Outlook (Revenue, USD Billion, 2021-2026)

·         Immunoassays

·         POC

·         Molecular Diagnostics

End-User Outlook (Revenue, USD Billion, 2021-2026)

·         Hospitals

·         Diagnostics Laboratories

·         Clinics

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America                                                                                 

  • The US.
  • Canada
  • Mexico

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

 

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of APAC

Central & South America

  • Brazil
  • Argentina
  • Rest of CSA

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Rest of MEA

 

Contact: Tracy Simon

Email address: tracy.simon@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

No comments:

Post a Comment